American Society of Human Genetics
Discover more biomarkers with Shasta NGS technologies
The 2024 ASHG Annual Meeting brought together scientists and patient care professionals from academia, industry, government, and the non-profit sectors to learn about the newest research and technology in the fields of human genetics and genomics. We hosted an industry education session featuring two scientists who discussed their research using our brand new Shasta Single Cell System and presented two featured posters at our booth. We shared our complete, novel solutions that can drive biomarker discovery and help you develop pioneering single-cell NGS assays using more cells than ever before.
Industry education session
Refining acute leukemia genomics through single-cell sequencing
In this talk, Dr. Ilaria Iacobucci from St. Jude Children's Research Hospital spoke about using single-cell sequencing of acute leukemia samples to dissect clonal diversity at an unprecedented resolution. This provided insights into the dynamic process of clonal evolution and allowed for a more accurate understanding of disease pathogenesis and classification.
TE-chimeric transcripts in cancer: From bulk to single-cell
In this talk, Colin McCornack from the Wang Lab at Washington University in St. Louis spoke about their recent work on the co-opting of transposable elements as cis-regulatory elements in cancer, with a special emphasis on recent efforts to uncover expression at the single-cell level using the new Shasta Single Cell System.
Featured posters
A novel, high-throughput, full gene-body scRNA-seq workflow for improved biomarker discovery
With this poster, we presented how the Shasta Single Cell System enables the preparation of high-quality, full gene-body RNA-seq libraries for up to 100,000 single cells per run with a unique barcoding strategy, which significantly improves the identification of new biomarkers.
Resolving tumor heterogeneity with a fully automated, high-throughput single-cell WGA workflow
With this poster, we presented how Shasta technology increases the cell throughput of single-cell WGA from 96 to 1,500 cells per run and enables the reliable detection of CNVs and SNVs at a shallow sequencing depth.
More cells. More biomarkers. More discoveries.
Want to go from sample prep through data analysis with less hands-on time and stress? Meet the Shasta Single Cell System, which helps oncology researchers find novel biomarkers. Learn how our high-throughput Shasta technologies can inspire the next breakthrough.
Get the detailsTakara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
